the effect of a 3 month daily administration of 800 mg pentoxifylline ( trental 400 bds ) or placebo was assessed under double blind crossover design in 18 patients ( 12 males and 6 females ) with peripheral occlusive arterial disease in respect of painfree walking distance and various hemorheological and hemostasiological variables , platelet aggregation , serum cholesterol and triglycerides .
C0030899
pentoxifylline
C0699487
trental